Clinical Trial Update: L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating L-glutamine to alleviate taxane-induced neuropathy in breast cancer patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Peripheral Neuropathy

Drugs mentioned

• L-GLUTAMINE (L-Glutamine)

Snippet

Sponsor: Eastern Regional Medical Center | Conditions: Peripheral Neuropathy | Phase 1 | Status: WITHDRAWN